Friend or foe: emerging role of nuclear factor kappa-light-chain-enhancer of activated B cells in cell senescence
Authors:
Open Access
- 1 September 2013
- journal article
- review article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. 6, 1221-9
Abstract
Peer reviewed article authored by (Mowla SN, Perkins ND, Jat PS). Read article or submit your manuscript for publishing.Keywords
This publication has 86 references indexed in Scilit:
- Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRHNature, 2013
- Targeting aurora kinases limits tumour growth through DNA damage‐mediated senescence and blockade of NF‐κB impairs this drug‐induced senescenceEMBO Molecular Medicine, 2012
- Cellular senescence: A link between cancer and age-related degenerative disease?Seminars in Cancer Biology, 2011
- Up and downregulation of p16Ink4a expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancerLaboratory Investigation, 2011
- p38MAPK is a novel DNA damage response‐independent regulator of the senescence‐associated secretory phenotypeThe EMBO Journal, 2011
- Targeting inflammatory pathways for tumor radiosensitizationBiochemical Pharmacology, 2010
- Role of NF-κB in the skeletonCell Research, 2010
- Healing and Hurting: Molecular Mechanisms, Functions, and Pathologies of Cellular SenescenceMolecular Cell, 2009
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasNature, 2007
- A Fourth IκB Protein within the NF-κB Signaling ModuleCell, 2007